The "GBA Gene Parkinson Disease Late-Onset Susceptibility to Genetic Test" is a specific diagnostic tool offered by DNA Labs UAE, designed to assess an individual's genetic predisposition to developing late-onset Parkinson's disease. This test focuses on mutations in the GBA gene, which have been linked to an increased risk of Parkinson's disease, a progressive neurological disorder that affects movement. The presence of certain mutations in the GBA gene can significantly elevate an individual's likelihood of developing this condition later in life.
At a cost of 4400 AED, the test provides a valuable insight for those who have a family history of Parkinson's disease or exhibit early symptoms, enabling them to take proactive measures in managing their health. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test involves a simple sample collection process, followed by comprehensive genetic analysis to identify any mutations associated with an increased risk of Parkinson's disease. The results from this test can guide individuals in making informed decisions regarding their health and lifestyle, potentially influencing treatment plans and preventive strategies to mitigate the impact of the disease.
The MT-TT gene, located within the mitochondrial genome, plays a crucial role in the proper functioning of mitochondria, the cell's energy-producing structures. Mutations in the MT-TT gene have been linked to an increased susceptibility to Parkinson's disease, a progressive neurological disorder characterized by motor symptoms such as tremors, stiffness, and bradykinesia, as well as non-motor symptoms. Understanding one's genetic predisposition to Parkinson's disease can be crucial for early detection, management, and potential preventive measures.
DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the MT-TT gene that may increase an individual's susceptibility to Parkinson's disease. This test is a valuable tool for those with a family history of Parkinson's or individuals who wish to assess their genetic risk for the disease. The test is priced at 4400 AED and involves a simple procedure to collect a DNA sample, typically through a blood draw or cheek swab. The collected sample is then analyzed in the lab to detect any genetic alterations in the MT-TT gene that might indicate a higher risk of developing Parkinson's disease.
Opting for the MT-TT related genetic test at DNA Labs UAE can empower individuals with crucial information about their health, allowing them to make informed decisions regarding their lifestyle, health monitoring, and potential interventions. It's an investment in one's health that could potentially alter the course of their life by providing the opportunity for early intervention and personalized health strategies.
The ATP6AP2 gene has been identified as a critical player in the development of a unique form of Parkinsonism characterized by spasticity, following an X-linked inheritance pattern. This condition, which combines features of Parkinson's disease with muscle stiffness and spasms, has led to the development of specialized genetic testing to diagnose the disorder accurately.
The genetic test for ATP6AP2 gene-related Parkinsonism with spasticity is available at DNA Labs UAE, a leading facility in genetic diagnostics. The test specifically targets mutations within the ATP6AP2 gene to confirm the diagnosis, enabling healthcare professionals to tailor treatment and management plans for affected individuals.
Priced at 4400 AED, the test is a valuable tool for families with a history of X-linked Parkinsonism with spasticity, offering them a clear understanding of their genetic status. This information is crucial for making informed decisions about future healthcare and for understanding the risk to other family members.
The SLC6A3 gene Parkinsonism-Dystonia Infantile genetic test is a specialized diagnostic tool designed to detect mutations in the SLC6A3 gene, which have been associated with the development of Parkinsonism-Dystonia in infancy. This rare genetic disorder is characterized by a combination of Parkinsonian symptoms such as tremors, rigidity, and bradykinesia, alongside dystonia, which involves involuntary muscle contractions leading to abnormal postures or movements. Early detection through genetic testing can be crucial for managing symptoms and improving the quality of life for affected individuals.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the SLC6A3 gene to identify any mutations that may be present. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed using advanced genetic sequencing technologies.
The cost of the SLC6A3 gene Parkinsonism-Dystonia Infantile genetic test is 4400 AED. While the price may seem significant, the value of early and accurate diagnosis cannot be overstated, as it opens the door to targeted treatments and interventions that can significantly benefit the patient. Individuals with a family history of Parkinsonism-Dystonia or those showing early symptoms of the disorder are encouraged to consider this test. It's also advisable to consult with a healthcare provider or a genetic counselor to understand the implications of the test results fully.
The PNKD Gene Paroxysmal Nonkinesigenic Dyskinesia Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the PNKD gene, which are linked to Paroxysmal Nonkinesigenic Dyskinesia (PNKD). This condition is characterized by sudden, involuntary movements that can include spasms, twisting motions, or flailing limbs, which occur without a specific trigger like sudden movement. Unlike other forms of dyskinesia, episodes are not initiated by kinesigenic activity and can last for minutes to hours.
The test is crucial for individuals showing symptoms of PNKD, as a positive identification of mutations in the PNKD gene can confirm the diagnosis, allowing for a tailored management plan. Early diagnosis can significantly improve the quality of life for individuals with PNKD by providing insights into potential triggers, effective treatments, and lifestyle adjustments.
At a cost of 4400 AED, the test is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific genetic alterations in the PNKD gene. Results from this test can provide definitive answers for affected individuals and their families, guiding decisions about management and care.
The ARX Gene Partington Syndrome Genetic Test is a specialized diagnostic procedure conducted at DNA Labs UAE, aimed at identifying mutations in the ARX gene, which are known to cause Partington syndrome. This rare genetic disorder is characterized by intellectual disability, dystonic hand movements, and sometimes epilepsy. The test involves analyzing the patient's DNA to detect abnormalities in the ARX gene that may lead to the development of this condition.
The cost of the ARX Gene Partington Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This comprehensive test is crucial for families seeking a definitive diagnosis of Partington syndrome, enabling them to understand the genetic basis of the condition and to explore potential treatment options and management strategies. By identifying the specific mutation, healthcare providers can offer personalized care and support to affected individuals and their families.
The PLP1 gene Pelizaeus-Merzbacher Disease (PMD) genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the PLP1 gene, which are responsible for causing Pelizaeus-Merzbacher Disease. PMD is a rare, genetic, central nervous system disorder characterized by a range of neurological symptoms, including motor abilities impairment, cognitive development issues, and coordination problems. The test is crucial for early diagnosis, which can aid in managing symptoms and improving the quality of life for affected individuals. The cost of the test is 4400 AED, making it an accessible option for those seeking comprehensive genetic analysis in the UAE. This test is particularly valuable for families with a history of PMD, offering them crucial information for family planning and management of the condition.
The SOX10 Gene Peripheral Demyelinating Neuropathy, Waardenburg Syndrome, and Hirschsprung Disease Genetic Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the SOX10 gene. These mutations are known to be associated with a range of conditions, including peripheral demyelinating neuropathy, Waardenburg Syndrome, and Hirschsprung Disease. The test is crucial for individuals who exhibit symptoms related to these conditions or have a family history, as it aids in confirming the diagnosis, understanding the risk of passing the genetic mutation to offspring, and making informed decisions about management and treatment options. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to accurately identify mutations in the SOX10 gene and provide reliable results.
The ARFGEF2 Gene Periventricular Heterotopia with Microcephaly Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the ARFGEF2 gene. These mutations are associated with the development of Periventricular Heterotopia (PH) accompanied by microcephaly, a rare genetic disorder. PH is characterized by the presence of nodules of neurons in inappropriate locations in the brain due to their failure to migrate to the correct positions during development. This condition can lead to a range of neurological issues, including seizures, developmental delay, and difficulties with coordination and balance. Microcephaly, on the other hand, is a condition where a baby's head is significantly smaller than expected, often due to abnormal brain development.
The test, which costs 4400 AED, involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab, and analyzing it for specific mutations in the ARFGEF2 gene that are known to cause this complex condition. The results from this genetic testing can provide crucial information for the diagnosis, management, and understanding of the patient's condition. It can also offer valuable insights for family planning and genetic counseling for families affected by Periventricular Heterotopia with microcephaly. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable testing results.
The "PEX3 Gene Peroxisome Biogenesis Disorder Type 10A Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the PEX3 gene. These mutations are associated with Peroxisome Biogenesis Disorder Type 10A (PBD10A), a rare genetic condition that affects the body's ability to produce peroxisomes. Peroxisomes are essential for various cellular functions, including lipid metabolism and the detoxification of harmful substances.
This genetic test is critical for early detection and management of PBD10A, enabling healthcare providers to develop a tailored treatment plan for affected individuals. The test involves collecting a DNA sample, typically through a blood draw, and analyzing the genetic material for specific mutations in the PEX3 gene.
Offered at a cost of 4400 AED, the test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The test's accuracy and the lab's reputation make it a valuable resource for families with a history of PBD10A or related symptoms, providing them with crucial information about their genetic health and guiding future medical decisions.
